Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Cash Flows from Operating Activities:
Net income	$ 9,434	$ 7,569
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	1,719	1,677
Deferred income tax benefit- net	(800)
Provision for bad debts	(194)	169
Stock issued for costs and expenses	2,239
Compensatory element of stock issuances	$ 27
Stock option exercised	2
(Increase) decrease in operating assets, net:
Accounts, medical and management fee receivable(s)	$ (2,701)	$ (2,215)
Notes receivable	12	17
Costs and estimated earnings in excess of Billings on uncompleted contracts		403
Inventories	(661)	(67)
Prepaid expenses and other current assets	(178)	77
Other assets	172	(35)
Increase (decrease) in operating liabilities, net:
Accounts payable	216	(491)
Other current liabilities	(2,590)	1,047
Customer advances	(163)	(436)
Billings in excess of costs and estimated earnings on uncompleted contracts		403
Other liabilities	170	75
Due to related medical practices	(17)	10
Net cash provided by operating activities	6,657	7,912
Cash Flows from Investing Activities:
Purchases of property and equipment	(1,507)	(409)
Cost of patents	(96)	(42)
Net cash used in investing activities	(1,603)	(451)
Cash Flows from Financing Activities:
Repayment of borrowings and capital lease obligations	(2,422)	(1,247)
Distributions to noncontrolling interests	(3,472)	(2,713)
Repayment of notes receivable from employee stockholders	4	4
Net cash used in financing activities	(5,890)	(3,956)
Net Increase in Cash and Cash Equivalents	(836)	3,505
Cash and Cash Equivalents - Beginning of Period	8,528	9,449
Cash and Cash Equivalents - End of Period	$ 7,692	$ 12,954